Generate a tailored SOP for Dr. Kevin Dalby. Improve your application with a focused, well-structured draft.
Kevin Dalby is a Professor at the University of Texas at Austin, serving as the Johnson & Johnson Centennial Professor in the College of Pharmacy. He is the Director of the Targeted Therapeutic Drug Discovery & Development Program (TTP) and the Pharm.D. Honors Program. Dalby's research is focused on cancer cell signaling and therapeutics, particularly the molecular mechanisms of signal transduction and the novel strategies to inhibit aberrant signaling in cancer cells. His work aims to understand how alterations in protein expression and regulation can influence cancer phenotypes. Dalby also explores the regulatory roles of mitogen-activated protein kinases (MAPKs) in cellular functions and the development of inhibitors against these pathways. Through his research, he emphasizes the importance of translational research to develop new therapies for cancer treatment. He has extensive educational background, including a Ph.D. in Chemistry from the University of Cambridge and has completed postdoctoral training at prestigious institutions. His projects employ state-of-the-art technologies to facilitate drug discovery and improve outcomes for cancer patients.
University of Texas at Austin • Austin, TX
Professor and Director at the College of Pharmacy specializing in Drug Discovery and Development.
General requirements for the Graduate School at UT Austin apply to all programs unless otherwise specified.